- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 182 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 184 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 282 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 368 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 459 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 250 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 279 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 222 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 402 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 292 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 300 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- April 2025
- 198 Pages
Global
From €4375EUR$4,995USD£3,797GBP

The Genomics Artificial Intelligence (AI) market is a rapidly growing sector of the genomics industry. It is focused on the development of AI-based solutions to enable the analysis of large-scale genomic data. These solutions are used to identify genetic variants associated with diseases, to develop personalized treatments, and to improve the accuracy of diagnostics. AI-based solutions are also used to identify novel drug targets and to develop new drugs.
The Genomics AI market is driven by the increasing availability of genomic data, the need for more accurate and personalized treatments, and the growing demand for AI-based solutions. The market is expected to continue to grow in the coming years, as more genomic data is collected and AI-based solutions become more widely adopted.
Some companies in the Genomics AI market include Illumina, BGI, Thermo Fisher Scientific, Genomics plc, and DNAnexus. Show Less Read more